title: Report of the Fifth meeting of the International Network for Pediatric Hemophilia: a focus on prophylaxis and immune tolerance induction.
authors.affiliation: Departments of Paediatrics and Malmö Centre for Thrombosis and Haemostasis, Lund University, Skåne University Hospital, SE-205 02, Malmö, Sweden. rolf.ljung@med.lu.se.
authors.forename: Rolf
authors.initials: R
authors.lastname: Ljung
authors.affiliation: Institute for Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany.
authors.forename: Johannes
authors.initials: J
authors.lastname: Oldenburg
authors.affiliation: Klinikum Bremen-Mitte, Ambulanz fuer Thrombose und Haemostasestoerungen, Bremen, Germany.
authors.forename: Günter
authors.initials: G
authors.lastname: Auerswald
authors.affiliation: Meander Hospital, Amersfoort, The Netherlands.
authors.forename: Marijke
authors.initials: M
authors.lastname: van den Berg
authors.affiliation: Nara Medical University, Kashihara, Japan.
authors.forename: Midori
authors.initials: M
authors.lastname: Shima
authors.affiliation: Division of Blood Disease and Resources, National Heart, Lung and Blood Institute, National Institute of Health, Bethesda, MD, USA.
authors.forename: Donna
authors.initials: D
authors.lastname: DiMichele
mesh_terms: D002648:Child; D005169:Factor VIII / Q000276:immunology / Q000627:therapeutic use; D006467:Hemophilia A / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D007108:Immune Tolerance; D011292:Premedication
chemical_list: D005169:Factor VIII